20 May 2026
TAVI for aortic regurgitation
Session comprising selected EuroPCR 2026 clinical cases submissions
Moderators:
O. Soliman, L. Testa
Summary
This session highlights innovative transcatheter aortic valve implantation (TAVI) approaches for treating aortic regurgitation, focusing on off-label uses and complex cases. It features high-risk patient interventions, including nonagenarian patients, and strategies to manage severe non-calcific native valve regurgitation with balloon-expandable valves.